|
Washington DC, (11 December 2024) - The Society of Interventional Oncology (SIO) is proud to receive the esteemed 2024 Pierre Award in recognition of its efforts in fundraising achievement. Awarded at the annual RevUP Summit hosted by the Professionals for Association Revenue (PAR), the Pierre Award recognizes the power of associations to enact impactful change within an industry through advancements in association business. The Pierre Award honors Christine Pierre’s legacy of association mission and business alignment, founder of the Society for Clinical Research Sites (SCRS).
SIO achieved an unprecedented fundraising achievement, raising $6 million for the “Ablation with Confirmation of Colorectal Liver Metastases (ACCLAIM) Prospective Trial for Microwave Ablation as a Local Cure,” the first multi-industry supported international clinical trial in interventional radiology.
“SIO’s vision to advance interventional oncology requires collaboration in many forms, and it has been an achievement for the entire specialty that we could bring together partners who share this commitment and advance it together through clinical research,” said Jena Eberly Stack, SIO Executive Director. “We are honored to share this story with the association and medical society community, and grateful to our valued industry partners who helped make this possible.”
SIO launched the ACCLAIM Trial in January 2022, with the goal to “establish microwave ablation (MWA) as the preferred treatment option for selected colorectal liver metastases that can be ablated with sufficient margins.” The trial is currently being conducted across 10 international sites with an estimated 275 patients. With the support of Boston Scientific Corporation, NeuWave Medical, Inc. (part of Ethicon, Inc.), and Varian, a Siemens Healthineers Company, the ACCLAIM Trial demonstrates the strength of collaboration and clinical trial expertise within the interventional oncology (IO) community. Constantinos Sofocleous, MD, PhD, FSIR, FCIRSE is the Global Principal Investigator of the study. Stack said the project laid the groundwork to learn the process of executing on projects aimed at increasing the levels of evidence for interventional oncologic therapies in partnership with expert stakeholders, both physician leaders and industry partners.
“The story of the ACCLAIM study is an illustration of the power of partnership, which is truly at the heart of interventional oncology, and all it is capable of achieving to improve outcomes for patients,” said Stack.
SIO joins the Infectious Disease Society of America (2022) and the Association of Clinical Research Professionals (2023) as the recipient of the prestigious annual award.
“We are proud to congratulate SIO on receiving the Pierre Award,” said Sean Soth, founder and chairman, PAR, and SVP, Strategy & Global Partnerships, SCRS. “This achievement shows the power of associations to drive meaningful change and advance their industries through innovative fundraising and collaboration. The $6 million raised for the ACCLAIM Trial exemplifies how uniting industry competitors can lead to groundbreaking advancements in patient care, setting a new standard for interventional oncology.”
| 
